However, patients with atopic dermatitis treated with < Invented Name > have not been found to have significant systemic pimecrolimus levels.
Siiski ei ole {Väljamõeldud nimetus} ravitud atoopilise dermatiidi patsientidel leitud pimekroliimuse arvestatavat süsteemset taset.